PP
EBS icon

PDT Partners’s Emergent Biosolutions EBS Stock Holding History

PDT Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,752
Closed -$131K – 537
2026
Q1 		$131K Buy
+15,752
New +$163K 0.01% 514
2025
Q3 		– Sell
-18,896
Closed -$121K – 615
2025
Q2 		$121K Buy
+18,896
New +$108K 0.01% 665
2024
Q3 		– Sell
-46,382
Closed -$316K – 749
2024
Q2 		$316K Buy
+46,382
New +$200K 0.03% 543
2022
Q4 		– Sell
-16,873
Closed -$354K – 707
2022
Q3 		$354K Sell
16,873
-24,993
-60% -$696K 0.05% 535
2022
Q2 		$1.3M Buy
41,866
+15,169
+57% +$518K 0.11% 306
2022
Q1 		$1.1M Buy
+26,697
New +$1.18M 0.09% 338
2015
Q4 		– Sell
-10,989
Closed -$313K – 547
2015
Q3 		$313K Buy
+10,989
New +$362K 0.01% 1040
2014
Q4 		– Sell
-17,096
Closed -$364K – 751
2014
Q3 		$364K Sell
17,096
-7,104
-29% -$163K 0.01% 1046
2014
Q2 		$544K Buy
24,200
+4,600
+23% +$107K 0.01% 954
2014
Q1 		$495K Buy
+19,600
New +$495K 0.01% 955

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

PDT Partners's EBS Position: Q2 2026 in Review

PDT Partners sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 15,752 shares — an estimated $131K sold.

PDT Partners first reported a position in EBS in Q1 2014 and held it in 10 quarters. The position peaked at $1.3M in Q2 2022. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • PDT Partners reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
  • PDT Partners sold 15,752 Emergent Biosolutions shares in Q2 2026, an estimated $131K.
  • PDT Partners first reported a position in Emergent Biosolutions in Q1 2014 and held it in 10 quarters.
  • PDT Partners's Emergent Biosolutions position peaked at $1.3M in Q2 2022.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.